GS Paper III · IPR · Economy · Science & Technology
🏛 Intellectual Property Rights (IPR) — Protecting the Fruits of Innovation
Definition · 7 Types of IP · Patent · Copyright · Trademark · GI Tag · TRIPS · WIPO · India's WIPI 2024 Rankings · Evergreening · Compulsory Licensing · Section 3(d) · National IPR Policy 2016 · PYQs & MCQs
💡
What are Intellectual Property Rights? — Rewarding Minds
Definition · UDHR · Objectives · Why They Matter
📖 Definition
Intellectual Property Rights (IPRs) are legal privileges granted to the creator or inventor that give them exclusive control over the use of their intellectual creation for a defined period of time. They protect creations of the human mind — inventions, literary and artistic works, symbols, names, designs, and traditional knowledge — ensuring creators can earn recognition and financial benefit from their work.
🧠 Simple Analogy — For All Students
Think of a farmer who grows crops. The government protects his physical land with property rights — no one can take it without permission. IPR is the same, but for mental labour. A scientist who spends 10 years developing a drug has the same right to protection of their intellectual "crop" as a farmer does of physical crops. Without IPR, companies would simply copy innovations without investing in R&D — killing the incentive to innovate.
📜 Constitutional & International Basis
Article 27, UDHR: "Everyone has the right to the protection of the moral and material interests resulting from any scientific, literary or artistic production of which he is the author."
India's Constitution: No explicit mention of IPR, but Article 19(1)(g) (right to profession/trade) and Article 300A (right to property) provide broad constitutional support. Parliament derives power to legislate on IPR from Entry 49, List I (Union List) of the Seventh Schedule.
India's Constitution: No explicit mention of IPR, but Article 19(1)(g) (right to profession/trade) and Article 300A (right to property) provide broad constitutional support. Parliament derives power to legislate on IPR from Entry 49, List I (Union List) of the Seventh Schedule.
🎯 Objectives of IPR
① Allow creators to profit financially and gain recognition
② Promote innovation by balancing inventors' interests with public interest
③ Encourage R&D — new technologies, medicines, cultural works
④ Protect traditional knowledge from biopiracy
⑤ Enable technology dissemination — patent documents are public
⑥ Foster fair competition and consumer protection
⑦ Support economic growth through knowledge-based industries
② Promote innovation by balancing inventors' interests with public interest
③ Encourage R&D — new technologies, medicines, cultural works
④ Protect traditional knowledge from biopiracy
⑤ Enable technology dissemination — patent documents are public
⑥ Foster fair competition and consumer protection
⑦ Support economic growth through knowledge-based industries
WIPO (World Intellectual Property Organization) — headquartered in Geneva, Switzerland. India joined WIPO in 1975. WIPO administers 26 international IP treaties including PCT (Patent Cooperation Treaty), Paris Convention (1883), and Berne Convention (1886). It has 193 member states. (Source: Wikimedia Commons)
India's GI Tag — Geographical Indications protect region-specific products. Darjeeling tea was India's first GI (2004–05). As of July 2025, India has 658 registered GI tags. Top states: Uttar Pradesh (leading), followed by Tamil Nadu. Administered by the Controller General of Patents, Designs and Trade Marks (CGPDTM). (Source: Wikimedia Commons)
🗂
7 Types of Intellectual Property — Complete Classification High Yield
Patent · Copyright · Trademark · GI · Trade Secret · Industrial Design · Plant Variety
🧠 Mnemonic — Remember All 7 Types
"People Can Take Great Trips In Planes"
Patent · Copyright · Trademark · Geographical Indication · Trade Secret · Industrial Design · Plant Variety Protection
Patent · Copyright · Trademark · Geographical Indication · Trade Secret · Industrial Design · Plant Variety Protection
⚗
1. Patent — Protection for Inventions
Duration: 20 years from filing date · Under Patents Act 1970 (amended 2005)
What: Exclusive right granted for an invention that is novel (new), non-obvious (involves inventive step), and industrially applicable. Products AND processes are patentable.
Rights granted: Patent holder can prevent others from commercially making, using, selling, or importing the patented invention without permission for 20 years from filing.
Public disclosure: In exchange for the patent, the inventor must publicly disclose full details — enabling knowledge dissemination and future innovation.
Rights granted: Patent holder can prevent others from commercially making, using, selling, or importing the patented invention without permission for 20 years from filing.
Public disclosure: In exchange for the patent, the inventor must publicly disclose full details — enabling knowledge dissemination and future innovation.
India-specific:
• Patents Act 1970 (major amendment 2005 to comply with TRIPS)
• Administered by CGPDTM (Controller General of Patents, Designs and Trade Marks)
• Section 3(d): Bars evergreening — cannot patent new forms of known substances without significant efficacy improvement
• Section 84: Compulsory Licensing — government can allow generic production if patented drug is unaffordable/unavailable
• India ranked 6th globally with 64,480 patent filings in 2023 (WIPI 2024)
• Patents Act 1970 (major amendment 2005 to comply with TRIPS)
• Administered by CGPDTM (Controller General of Patents, Designs and Trade Marks)
• Section 3(d): Bars evergreening — cannot patent new forms of known substances without significant efficacy improvement
• Section 84: Compulsory Licensing — government can allow generic production if patented drug is unaffordable/unavailable
• India ranked 6th globally with 64,480 patent filings in 2023 (WIPI 2024)
📚
2. Copyright — Protection for Creative Works
Duration: Life of author + 60 years · Under Copyright Act 1957
What: Automatic protection for original creative and artistic works from the moment of creation — no registration required. Protects the expression of ideas, not the ideas themselves.
Works covered: Books, music, films, paintings, sculptures, computer programs, databases, maps, technical drawings, advertisements, architectural plans, performances, broadcasts.
Duration: Life of the author + 60 years in India (50 years under TRIPS minimum). Films, photographs, posthumous works have separate durations.
Works covered: Books, music, films, paintings, sculptures, computer programs, databases, maps, technical drawings, advertisements, architectural plans, performances, broadcasts.
Duration: Life of the author + 60 years in India (50 years under TRIPS minimum). Films, photographs, posthumous works have separate durations.
Key concepts:
• Moral rights: Right of attribution and right to object to modifications — exist in India (Section 57, Copyright Act)
• Fair use (Fair dealing in India): Limited use for education, research, criticism without permission
• Related rights: Performers' rights (actors, musicians), phonogram producers' rights, broadcasting organisations' rights
• No registration needed — automatic protection from creation. However, registration provides legal evidence.
• Moral rights: Right of attribution and right to object to modifications — exist in India (Section 57, Copyright Act)
• Fair use (Fair dealing in India): Limited use for education, research, criticism without permission
• Related rights: Performers' rights (actors, musicians), phonogram producers' rights, broadcasting organisations' rights
• No registration needed — automatic protection from creation. However, registration provides legal evidence.
™
3. Trademark — Protection for Brand Identity
Duration: 10 years (renewable indefinitely) · Under Trademarks Act 1999
What: A distinctive sign, symbol, word, phrase, logo, or combination that identifies and distinguishes goods/services of one enterprise from another. Trademarks build brand value and consumer trust.
Types: Word marks (TATA, Amul), Device marks (logos), Service marks (for services), Certification marks (quality standards), Collective marks (for associations).
Types: Word marks (TATA, Amul), Device marks (logos), Service marks (for services), Certification marks (quality standards), Collective marks (for associations).
India stats (WIPI 2024): India ranked 4th globally in trademark filings (6.1% increase in 2023). Over 3.2 million active trademark registrations — world's 2nd largest. Nearly 90% of filings by domestic residents. Top sectors: Health (21.9%), Agriculture (15.3%), Clothing (12.8%).
Duration & renewal: Initially protected for 10 years from filing date. Can be renewed indefinitely every 10 years — making trademarks potentially perpetual (unlike patents or copyrights which have fixed terms). This is a key distinction.
🗺
4. Geographical Indications (GI Tags) — Protection for Place-Linked Products
Duration: 10 years (renewable indefinitely) · Under GI Act 1999
What: Labels applied to products that have a specific geographical origin and possess qualities, reputation, or characteristics attributable to that place. GIs protect both the product's authenticity and the livelihoods of regional producers.
Examples from India: Darjeeling Tea · Champagne (France) · Basmati Rice · Kashmir Saffron · Mysore Silk · Kancheepuram Silk · Alphonso Mango (Ratnagiri) · Tirupati Laddoo · Odisha Rasgulla · Similipal Kai Chutney (2024 — from red weaver ants)
India's GI count: 658 GI tags as of July 2025. First GI: Darjeeling Tea (2004–05). Up from 635 in March 2024.
Examples from India: Darjeeling Tea · Champagne (France) · Basmati Rice · Kashmir Saffron · Mysore Silk · Kancheepuram Silk · Alphonso Mango (Ratnagiri) · Tirupati Laddoo · Odisha Rasgulla · Similipal Kai Chutney (2024 — from red weaver ants)
India's GI count: 658 GI tags as of July 2025. First GI: Darjeeling Tea (2004–05). Up from 635 in March 2024.
Top GI states: Uttar Pradesh (leading, 69+ products including 30 from Varanasi alone: Banaras Thandai, Banaras Shehnai, Banaras Lal Peda, etc.) followed by Tamil Nadu.
2024–25 latest: Similipal Kai Chutney (Odisha, red weaver ants — tribal knowledge), Arunachal Yak Churpi, Khaw Tai rice, Tangsa textile; Hyderabad Lac Bangles.
2024–25 latest: Similipal Kai Chutney (Odisha, red weaver ants — tribal knowledge), Arunachal Yak Churpi, Khaw Tai rice, Tangsa textile; Hyderabad Lac Bangles.
2025 controversy: Prada's Spring/Summer 2026 show at Milan featured footwear inspired by India's GI-tagged Kolhapuri chappals — raising questions about global enforceability of GIs and cultural appropriation.
🏭
5. Industrial Designs
Duration: 10 years (renewable once to 15 yrs) · Designs Act 2000
The aesthetic or ornamental aspect of a product — 2D (patterns, colours) or 3D (shape, surface). Protects the visual appearance, not the function. Example: the unique shape of a Coke bottle, phone design, textile pattern. India's industrial design applications grew 36.4% in 2023 (WIPI 2024).
🔐
6. Trade Secrets
Duration: Indefinite as long as secret kept
Confidential business information providing competitive advantage — formulas, processes, customer lists, business strategies. Not publicly disclosed (unlike patents). Examples: Coca-Cola formula, Google's search algorithm, KFC's recipe. Protected by contract law and trade secret laws. No registration — protection lasts as long as the secret is maintained.
🌱
7. Plant Variety Protection (PVP)
Duration: 15 years (18 years for trees/vines) · Protection of Plant Varieties and Farmers' Rights Act 2001
Protects new, distinct, uniform, and stable plant varieties developed by breeders. Unique to India: The Protection of Plant Varieties and Farmers' Rights Act 2001 also includes Farmers' Rights — farmers can save, use, sow, re-sow, exchange, share, or sell seeds of protected varieties (except as branded seed). This balances breeders' commercial rights with farmers' traditional practices. Relevant to GM crop policy debates.
| Type | What It Protects | Duration | India's Law | Registration? |
|---|---|---|---|---|
| Patent | Inventions (new, non-obvious, applicable) | 20 years (non-renewable) | Patents Act 1970 (amended 2005) | Required |
| Copyright | Creative/artistic works | Life + 60 years | Copyright Act 1957 | Automatic (optional) |
| Trademark | Brand signs/symbols/names | 10 years (renewable indefinitely) | Trademarks Act 1999 | Required |
| GI Tag | Region-specific products | 10 years (renewable indefinitely) | GI Act 1999 | Required |
| Trade Secret | Confidential business information | Indefinite (as long as secret) | Contract law + common law | No registration |
| Industrial Design | Aesthetic/ornamental product design | 10 years (once renewable to 15) | Designs Act 2000 | Required |
| Plant Variety | New plant varieties (+ farmers' rights) | 15 years (18 for trees/vines) | PPVFR Act 2001 | Required |
🌍
International IP Framework — WIPO, TRIPS & Key Conventions
Paris Convention · Berne Convention · PCT · TRIPS · WIPO
| Convention/Treaty | Year | Body | Key Provisions |
|---|---|---|---|
| Paris Convention (Industrial Property) | 1883 | WIPO | World's first major IP treaty. Covers patents, trademarks, industrial designs, utility models, GIs, trade names. Established National Treatment principle (foreign applicants treated same as domestic). Created "Right of Priority" — filing in one country gives 12-month priority in others. |
| Berne Convention (Copyright) | 1886 | WIPO | Governs copyright internationally. Key principle: Automatic protection — no registration needed, protection the moment of creation. Minimum protection: life + 50 years. National treatment. India is a signatory. |
| Patent Cooperation Treaty (PCT) | 1970 | WIPO | Single application filing for patent protection in multiple countries simultaneously. Standardised process across 157 signatory states. Delays the cost of international patent protection — gives applicants up to 30 months to decide which countries to pursue. India joined PCT in 1998. |
| Budapest Treaty | 1977 | WIPO | International recognition of deposit of microorganisms for patent procedures. A depositor need only deposit a microorganism in one recognised depository (IDA) and this is accepted worldwide for patent purposes. |
| TRIPS Agreement | 1994 | WTO | Trade-Related Aspects of Intellectual Property Rights — most comprehensive IP agreement. Sets minimum standards for all IP types (patents: 20 years; copyrights: life+50 years). Three pillars: Standards · Enforcement · Dispute Settlement. All WTO members (including India) must comply. India had to amend its Patents Act in 2005 to comply with TRIPS. Most tested UPSC fact on TRIPS |
| Marrakesh Treaty | 2013 | WIPO | Facilitates creation and cross-border transfer of books in accessible formats for visually impaired and persons with print disabilities. Creates exceptions to copyright law. India ratified in 2014. Significant for inclusive education. |
| WIPO GRATK Treaty | May 2024 | WIPO | First WIPO treaty on IP, Genetic Resources and Traditional Knowledge. Mandatory patent disclosure of GR/TK country of origin. First treaty with provisions for Indigenous Peoples. Major win for India and Global South. Needs 15 ratifications to enter force. |
🔑 WIPO — Key Facts
World Intellectual Property Organization (WIPO) is a specialised agency of the United Nations dedicated to promoting protection of intellectual property worldwide through cooperation among states. HQ: Geneva, Switzerland. 193 member states. India joined in 1975. Started operations in 1970. WIPO administers 26 international IP treaties. Also publishes the Global Innovation Index (GII) and World Intellectual Property Indicators (WIPI) annually — both highly tested in UPSC.
🇮🇳
India's IPR Story — Policies, Rankings & Latest Data Current Affairs
WIPI 2024 · GII Ranking · National IPR Policy 2016 · CIPAM · Patents Amendment 2024
📊 India's IP Performance — WIPI 2024 & WIPI 2025 Reports Current Affairs
Patents (Global Rank)
64,480 (2023)
Patent Growth
5th consec. year double-digit
Resident Filings
domestic applicants
Trademarks (Global Rank)
+6.1% in 2023
Active TM Registrations
World's 2nd largest
Industrial Design
Fastest growing
GI Tags (July 2025)
First: Darjeeling Tea (2004)
For the first time in WIPI 2024, India ranked in the top 10 globally across ALL three major IP categories (Patents, Trademarks, Industrial Designs). Patent-to-GDP ratio has risen from 144 to 381 over the last decade. S&T Cluster Ranking: India 4th (Mumbai, Delhi, Bengaluru, Chennai in top 100).
🌐 Global Innovation Index (GII) — India's Rise
Published by WIPO annually. Measures innovation inputs and outputs across 133 economies. India's journey:
81st
GII Rank 2015
52nd
GII Rank 2019
38th-39th
GII Rank 2024-25
India excels in intangible asset intensity (7th globally), innovation outputs (33rd), and S&T clusters. Consistent improvement reflects National IPR Policy 2016's impact.
| Policy/Institution | Year | Key Details |
|---|---|---|
| National IPR Policy | 2016 | Unifies all IPRs on one platform. 7 objectives: awareness, generation, legal & legislative framework, administration, commercialisation, enforcement, human capital development. Acknowledges traditional knowledge. Seeks to convert knowledge into IP assets for economic benefit. |
| CIPAM (Cell for IPR Promotion and Management) | 2016 | Implements National IPR Policy. Under DPIIT (Department for Promotion of Industry and Internal Trade). Promotes IPR awareness, commercialisation, and enforcement. Runs IP sensitisation programmes for industry, startups, and academia. |
| KAPILA Programme | 2020 | Kalam Programme for IP Literacy and Awareness. Targets faculty and students in Higher Education Institutions (HEIs). Raises awareness about filing IP, the processes involved, and Indian/global IP laws. Part of innovation ecosystem development. |
| Patents (Amendment) Rules 2024 | 2024 | Key changes: (1) Certificate of Inventorship introduced — acknowledges inventor's contribution. (2) Time limit for filing request for examination reduced from 48 months to 31 months. (3) Foreign application filing details: 6 months → 3 months. (4) Renewal fee reduced by 10% for advance electronic payment. Aimed at fostering innovation and reducing pendency. |
| CGPDTM | Statutory | Controller General of Patents, Designs and Trade Marks — administers Patents Act, Designs Act, Trademarks Act, and GI Act. Key official for all industrial property in India. |
| Startup India & IP | 2016 | Startups get 80% rebate on patent fees. Expedited patent examination. IP facilitation centres in major innovation hubs. India has 3rd largest startup ecosystem globally — strong IP protection is crucial for their survival. |
⚠
Key Issues in IPR — Debates India Must Navigate
Evergreening · Compulsory Licensing · Section 3(d) · TRIPS Flex
🔄 Evergreening of Patents High Yield
What: Practice where pharmaceutical companies extend patent monopoly by filing new patents for minor modifications of existing drugs (new salt form, new dosage, new delivery method) without significant therapeutic benefit — to prevent generic competition beyond the 20-year original patent.
Impact: Keeps drug prices artificially high. Delays generic entry. Harms public access to affordable medicines.
Impact: Keeps drug prices artificially high. Delays generic entry. Harms public access to affordable medicines.
India's defence — Section 3(d): The Indian Patents Act 1970 (as amended 2005) includes Section 3(d) — which states that new forms of a known substance (new salts, new forms, new dosages, new compositions) are NOT patentable UNLESS they demonstrate significantly enhanced efficacy compared to the known substance.
Novartis v. Union of India (2013): Supreme Court upheld Section 3(d) — rejected Novartis's patent for Glivec (imatinib mesylate, a cancer drug). Landmark case showing India can resist evergreening while complying with TRIPS. Called a victory for global public health.
Novartis v. Union of India (2013): Supreme Court upheld Section 3(d) — rejected Novartis's patent for Glivec (imatinib mesylate, a cancer drug). Landmark case showing India can resist evergreening while complying with TRIPS. Called a victory for global public health.
⚖ Compulsory Licensing (CL) — Section 84, Patents Act
What: Government authorises a third party to produce, use, import, or sell a patented product/process WITHOUT the patent holder's consent, usually in cases of public health emergency, unaffordable prices, or insufficient domestic supply.
Grounds for CL in India (Section 84):
• Reasonable requirements of the public not satisfied
• Drug not available at reasonably affordable price
• Not manufactured in India (working requirement)
Grounds for CL in India (Section 84):
• Reasonable requirements of the public not satisfied
• Drug not available at reasonably affordable price
• Not manufactured in India (working requirement)
India's landmark CL (2012): Controller General of Patents granted compulsory licence to Natco Pharma for Bayer's cancer drug Nexavar (Sorafenib) — allowing Natco to sell the drug at ₹8,880 vs Bayer's price of ₹2.8 lakh per month. First CL ever granted in India — a global milestone.
TRIPS flexibility: TRIPS Article 31 permits CL under specific conditions. The Doha Declaration (2001) on TRIPS and Public Health explicitly confirmed developing countries' right to use CL for public health reasons — important precedent for India.
Foreign investor concern: CL is seen as a risk to IP security by foreign pharma and technology investors.
TRIPS flexibility: TRIPS Article 31 permits CL under specific conditions. The Doha Declaration (2001) on TRIPS and Public Health explicitly confirmed developing countries' right to use CL for public health reasons — important precedent for India.
Foreign investor concern: CL is seen as a risk to IP security by foreign pharma and technology investors.
💊
Access vs Innovation Dilemma
Strong IPR → high drug prices → unaffordable in developing countries. Weak IPR → no R&D investment → no new drugs. India balances this through Section 3(d), CL provisions, and generic drug manufacturing capacity (world's pharmacy — 20% of global generic supply).
🏴☠
Piracy & Counterfeiting
India loses significant economic value to copyright piracy (films, software, music) and counterfeit goods. CIPAM and enforcement agencies address this. Digital era has exponentially increased piracy risks. India is on USTR's "Priority Watch List" for IP enforcement — a trade friction point.
🌐
Data Exclusivity Debate
Developed countries (especially USA through FTAs) push India to adopt "data exclusivity" — preventing generic manufacturers from using clinical trial data submitted by innovators for a set period, even after patent expiry. India has resisted this as it would further delay generic competition and harm public health.
🤖
AI & IPR — New Frontier
Can AI systems hold patents? Can AI-generated art be copyrighted? No existing IP law covers AI inventorship. India's Patents Office and WIPO are grappling with these questions. The WIPO AI-IP consultation process (2023–24) is exploring global standards — a live UPSC current affairs angle.
🌿
Biopiracy & Traditional Knowledge
Corporations patent indigenous knowledge (turmeric, neem) without benefit-sharing. India's TKDL defends against this. WIPO GRATK Treaty 2024 addresses the interface between patents and TK. Section 3(p) of Patents Act bars patents on traditional knowledge or aggregation of known properties.
📉
Patent Backlog & Pendency
India's Patent Office has a significant backlog of patent applications — examination delays can stretch 4+ years. Patents (Amendment) Rules 2024 reduced examination request timeline from 48 to 31 months to address this. Automation and manpower augmentation ongoing.
📜
PYQs & Practice MCQs
UPSC Prelims & Mains · Direct Hits · IPR, TRIPS, GI Tags
📜 UPSC Prelims 2019 — GS Paper I
PYQ 2019
Q. Consider the following statements:
1. The Patent Cooperation Treaty provides a unified procedure for filing patent applications to protect inventions in its member states.
2. Patent Cooperation Treaty is administered by the World Trade Organisation.
3. Under the TRIPS Agreement, a patent must be granted for minimum 20 years.
1. The Patent Cooperation Treaty provides a unified procedure for filing patent applications to protect inventions in its member states.
2. Patent Cooperation Treaty is administered by the World Trade Organisation.
3. Under the TRIPS Agreement, a patent must be granted for minimum 20 years.
- a) 1 and 3 only
- b) 1 and 3 only ✓
- c) 2 and 3 only
- d) 1, 2 and 3
Statement 1 CORRECT: The Patent Cooperation Treaty (PCT, 1970) provides a single, unified international filing procedure that allows inventors to simultaneously seek patent protection in multiple countries through one application. It streamlines the process and delays costs of pursuing international patents.
Statement 2 WRONG: PCT is administered by WIPO (World Intellectual Property Organization) — NOT the World Trade Organization (WTO). WTO administers the TRIPS Agreement. WIPO and WTO are separate international organisations. WIPO is a UN specialised agency; WTO is an independent intergovernmental organisation. Never confuse these two.
Statement 3 CORRECT: Under TRIPS Article 33, patent protection must be available for a minimum of 20 years from the date of filing. This is a binding standard for all WTO members.
Statement 2 WRONG: PCT is administered by WIPO (World Intellectual Property Organization) — NOT the World Trade Organization (WTO). WTO administers the TRIPS Agreement. WIPO and WTO are separate international organisations. WIPO is a UN specialised agency; WTO is an independent intergovernmental organisation. Never confuse these two.
Statement 3 CORRECT: Under TRIPS Article 33, patent protection must be available for a minimum of 20 years from the date of filing. This is a binding standard for all WTO members.
📜 UPSC Prelims 2017 — GS Paper I
PYQ 2017
Q. "Berne Convention" that was amended in 1979 relates to
- a) Wildlife conservation
- b) Copyrights on literary and artistic works ✓
- c) Intellectual property rights related to biodiversity
- d) Protection of industrial designs
The Berne Convention for the Protection of Literary and Artistic Works (1886) is the foundational international treaty governing copyright. It was amended multiple times, significantly in 1979. Key principles: (1) Automatic protection — no formalities required, copyright exists from the moment of creation; (2) National treatment — foreign works receive same protection as domestic works; (3) Minimum protection standards — life of author + 50 years minimum. Administered by WIPO. The Paris Convention (1883) protects industrial property (patents, trademarks). The Berne Convention specifically and exclusively covers literary and artistic works (copyrights).
📜 UPSC Mains 2016 — GS Paper III (15 marks)
Mains 2016
Q. How does the issue of intellectual property rights affect India's pharmaceutical sector? (15 marks)
Model Answer Framework:
Model Answer Framework:
- Context: India = "pharmacy of the world" — 20% of global generic medicines supply. TRIPS compliance (2005 amendment to Patents Act) created tensions between innovation incentives and public health access.
- Impact of TRIPS on pharma: Product patents mandatory (India shifted from process-only patents in 1970 Act). Generic companies cannot copy patented drugs. Higher drug prices for 20-year patent period.
- Section 3(d) — India's safeguard: Bars evergreening of patents. New forms/salts/dosages of known substances need to show enhanced efficacy. Novartis v. India (2013) SC upheld this — landmark for global health.
- Compulsory Licensing: Section 84 allows CL when drug is unaffordable. Natco-Bayer (2012) — Nexavar cancer drug CL. First in India. Drug price: ₹2.8 lakh → ₹8,880. TRIPS Article 31 + Doha Declaration support this.
- US pressure — Special 301 Report: India on USTR Priority Watch List for IPR enforcement. US pressures India on data exclusivity, evergreening, patent linkage. India resists these TRIPS-Plus demands.
- Innovation vs access: Weak IP may discourage pharma R&D investment. Strong IP harms public health. India's balanced approach through generic competition + TRIPS flexibilities is globally respected.
- Way forward: Strengthen domestic pharma R&D (production-linked incentives); use TRIPS flexibilities judiciously; push for TRIPS waiver for life-saving drugs at WTO (India-South Africa COVID-19 vaccine waiver proposal); robust IP enforcement ecosystem for homegrown innovation.
🧪 Practice MCQs — IPR (Click to attempt)
Q1. Which of the following correctly describes "Section 3(d)" of India's Patents Act 1970?
- (a) It mandates compulsory licensing for all pharmaceutical patents after 10 years
- (b) It provides for patents on traditional knowledge that has been scientifically validated
- (c) It prohibits patents on new forms of known substances (such as new salts, new forms, new dosages) unless they demonstrate significantly enhanced efficacy compared to the known substance
- (d) It requires all patent applicants to disclose the country of origin of genetic resources used in the invention
Section 3(d) of the Indian Patents Act (introduced through the 2005 TRIPS-compliance amendment) is India's key safeguard against evergreening. It specifically states that new forms of a known substance — including new salts, esters, ethers, polymorphs, metabolites, pure forms, particle sizes, isomers, mixtures of isomers, complexes, combinations, and new dosage forms — are NOT patentable unless they result in significantly enhanced efficacy (not just bioavailability or other properties). The Supreme Court in Novartis v. Union of India (2013) upheld this provision when Novartis tried to patent Glivec (imatinib mesylate), a new form of a known compound. The Court held that the new beta-crystalline form did not show enhanced therapeutic efficacy over the known compound — patent rejected. This case is globally cited as a landmark in balancing IPR and public health.
Q2. As per the WIPO World Intellectual Property Indicators (WIPI) 2024 report, India's performance in IP filings includes which of the following?
1. India ranked 6th globally in patent filings with 64,480 applications in 2023 — a 15.7% growth.
2. India ranked 4th globally in trademark filings.
3. India ranked in the top 10 across all three major IP categories (patents, trademarks, industrial designs) for the first time.
4. India's industrial design applications grew by 36.4% in 2023.
1. India ranked 6th globally in patent filings with 64,480 applications in 2023 — a 15.7% growth.
2. India ranked 4th globally in trademark filings.
3. India ranked in the top 10 across all three major IP categories (patents, trademarks, industrial designs) for the first time.
4. India's industrial design applications grew by 36.4% in 2023.
- (a) 1 and 2 only
- (b) 1, 2 and 3 only
- (c) 2, 3 and 4 only
- (d) 1, 2, 3 and 4 — all correct
All four statements are correct, based on the WIPO World Intellectual Property Indicators (WIPI) 2024 report. Statement 1: India filed 64,480 patent applications in 2023, ranking 6th globally — a 15.7% increase, marking the fifth consecutive year of double-digit growth. Over 55% of filings were from domestic applicants. Statement 2: India ranked 4th globally in trademark filings with a 6.1% increase in 2023; nearly 90% of filings by domestic residents; 3.2 million active trademark registrations (world's 2nd largest). Statement 3: For the first time, India entered the top 10 in all three major IP categories simultaneously — a historic milestone reflecting the impact of the National IPR Policy 2016 and broader innovation ecosystem development. Statement 4: India's industrial design applications grew by 36.4% in 2023, with robust growth in textiles, tools, and health sectors. Additionally, India ranked 39th in the Global Innovation Index 2024 (improved from 81st in 2015).
Q3. India's first Geographical Indication (GI) tag was granted to which product, and in which year?
- (a) Mysore Silk — 2001
- (b) Darjeeling Tea — 2004–05
- (c) Basmati Rice — 2000
- (d) Kashmir Saffron — 2003
Darjeeling Tea was the first product to receive a Geographical Indication tag in India, in 2004–05. The Geographical Indications of Goods (Registration and Protection) Act was passed in 1999 and came into force on 15 September 2003. Darjeeling Tea was the first GI registered under this Act. As of July 2025, India has 658 registered GI tags — a number growing steadily. Uttar Pradesh leads with the highest number (69+ GI-tagged products), with Varanasi alone having 30 certified products. The GI Registry is administered by the Controller General of Patents, Designs and Trade Marks (CGPDTM) under the Department for Promotion of Industry and Internal Trade (DPIIT).
Q4. The "Doha Declaration on TRIPS and Public Health" (2001) was significant because:
- (a) It extended the period of patent protection for pharmaceutical products to 25 years in developing countries
- (b) It banned pharmaceutical companies from evergreening cancer and HIV drugs in WTO member countries
- (c) It confirmed that WTO member countries, especially developing nations, have the right to use compulsory licensing and other TRIPS flexibilities to protect public health and promote access to affordable medicines
- (d) It created a global fund for purchasing patented medicines for developing countries at subsidised prices
The Doha Declaration on TRIPS and Public Health, adopted by WTO member states at the Doha Ministerial Conference in November 2001, was a landmark clarification of TRIPS flexibilities. It explicitly stated that the TRIPS Agreement "does not and should not prevent members from taking measures to protect public health" and that it "should be interpreted and implemented in a manner supportive of WTO members' right to protect public health." Specifically, it confirmed the right of developing countries to: (1) issue compulsory licences for medicines and determine the grounds for such licences; (2) determine what constitutes a national emergency that triggers CL (including HIV/AIDS, TB, malaria, and other epidemics). This was the international legal basis India used when it granted the Natco-Bayer compulsory licence in 2012 for Nexavar (sorafenib, a cancer drug). India also co-led (with South Africa) the 2020 WTO proposal for a TRIPS waiver for COVID-19 vaccines and therapeutics — building on the Doha Declaration precedent.
Q5. Which of the following forms of intellectual property has potentially unlimited duration?
- (a) Patent
- (b) Trademark
- (c) Copyright
- (d) Industrial Design
A Trademark has potentially unlimited duration — it is renewable indefinitely every 10 years as long as it remains in use and renewal fees are paid. This is the only form of IP that can theoretically last forever. Compare: Patent = fixed 20 years (non-renewable). Copyright = Life + 60 years (India) — fixed, not renewable. Industrial Design = 10 years, renewable once to 15 years maximum. Trade Secrets are also indefinitely protected, but only as long as the secret is maintained — if the secret is disclosed or independently discovered, protection ends. A trademark can remain valid for centuries — for example, the Bass Pale Ale triangle trademark (first registered trademark in the UK, 1876) is still in use. Brands like Coca-Cola (trademark since 1893), TATA, Amul are perpetually protected through renewal. This distinction between trademarks (perpetual) and patents (time-limited) is a classic UPSC question.
⚡ Quick Revision — IPR Summary
| Topic | Key Facts to Remember |
|---|---|
| Definition | Legal privileges protecting creations of the human mind (inventions, arts, brands, regional products). Gives exclusive rights for defined period. Article 27, UDHR. Balances creator rights with public interest. |
| Patent | 20 years, non-renewable. Must be novel + non-obvious + industrially applicable. Products and processes both patentable. India: Patents Act 1970 (amended 2005 for TRIPS). CGPDTM administers. Section 3(d): bars evergreening. Section 84: compulsory licensing. |
| Copyright | Automatic (no registration). Protects literary/artistic works. Duration: Life + 60 years (India). Berne Convention (1886). Covers books, music, films, software, databases, maps. Also: performers' rights, broadcast rights. |
| Trademark | 10 years, INDEFINITELY renewable. Protects brand identity (signs, symbols, words, logos). India: 4th globally in TM filings (WIPI 2024). 3.2 million active TMs — world's 2nd largest. Trademarks Act 1999. |
| GI Tag | 10 years, indefinitely renewable. Region-specific products with qualities from that origin. First GI: Darjeeling Tea (2004–05). India: 658 GI tags (July 2025). GI Act 1999. Top state: Uttar Pradesh (69+). Administered by CGPDTM. |
| WIPO | UN specialised agency. HQ: Geneva. 193 members. India: 1975. Administers Paris Convention (1883), Berne Convention (1886), PCT (1970), Marrakesh Treaty, WIPO GRATK Treaty 2024. Publishes GII and WIPI. |
| TRIPS | WTO agreement, 1994. Sets minimum IP standards globally: patents 20 years, copyright life+50 years. Three pillars: Standards, Enforcement, Dispute Settlement. India amended Patents Act 2005 to comply. Doha Declaration 2001 clarified flexibilities for public health. |
| Section 3(d) | Indian Patents Act — bars evergreening. New forms of known substances (salts, dosages) not patentable unless significantly enhanced EFFICACY shown. Novartis v. India 2013: SC upheld — Glivec patent rejected. Global landmark for public health. |
| Compulsory Licensing | Section 84 — government allows generic use of patented drug without patent holder consent. Grounds: unaffordable, unavailable, not manufactured in India. Natco-Bayer 2012: first India CL — Nexavar price ₹2.8L → ₹8,880. TRIPS Article 31 + Doha Declaration support. |
| India WIPI 2024 | Patent: 6th globally (64,480, +15.7%). Trademark: 4th globally (+6.1%). Industrial Design: +36.4%. First time top 10 in all three. Patent-to-GDP ratio: 144→381. GII: 81st (2015) → 38th-39th (2024-25). S&T Cluster Rank: 4th. |
| National IPR Policy 2016 | Unifies all IPRs. 7 objectives. CIPAM (under DPIIT) implements. KAPILA programme for awareness. Patents (Amendment) Rules 2024: Certificate of Inventorship; exam request reduced 48→31 months. |
| Evergreening | Filing patents for minor modifications of existing drugs to extend monopoly beyond 20 years. India blocks via Section 3(d). Harms access to affordable medicines. Pharma companies' strategy vs public health concern. |
🚨 5 UPSC Traps — IPR:
Trap 1 — "PCT (Patent Cooperation Treaty) is administered by WTO" → WRONG! PCT is administered by WIPO (World Intellectual Property Organization). WTO administers the TRIPS Agreement. WIPO and WTO are entirely separate international organisations with different memberships, mandates, and headquarters. This was directly tested in UPSC 2019. Never confuse WIPO (UN agency, Geneva, IPR treaties) with WTO (trade organisation, Geneva, TRIPS and trade rules).
Trap 2 — "Trademark protection lasts 10 years and expires" → WRONG! Trademark registration lasts 10 years but is renewable indefinitely. A trademark can last forever as long as renewal fees are paid and it remains in active use. This is fundamentally different from patents (fixed 20 years, non-renewable) and copyrights (fixed life+60 years). Trademarks are the ONLY major IP right with potentially unlimited duration.
Trap 3 — "Copyright requires registration to be valid" → WRONG! Copyright protection is automatic from the moment of creation — no registration, no formalities, no fees required. This is established by the Berne Convention (1886) principle of "automatic protection." Registration is optional in India (Copyright Act 1957 allows it) and provides legal evidentiary benefits but is NOT a prerequisite for copyright protection. This is a classic UPSC misdirection.
Trap 4 — "Section 3(d) violates India's TRIPS obligations" → WRONG! Section 3(d) does NOT violate TRIPS. TRIPS Article 27.1 requires patents for inventions that are new, involve an inventive step and are capable of industrial application. Trivial modifications (new salt forms, new dosages without efficacy improvement) do NOT meet the "inventive step" requirement. India's Supreme Court (Novartis v. India 2013) held that Section 3(d) is fully compliant with TRIPS — it simply clarifies what counts as a genuine inventive step in pharmaceuticals. The Court rejected the argument that TRIPS required granting such patents.
Trap 5 — "India's GI tags are protected globally like patents" → WRONG! GI protection is territorial — a GI tag registered in India protects the product only within India. For global protection, India must separately register the GI in each target country or region. This is why the Basmati case in the USA was problematic — India's domestic GI had no force in the US patent office. The Prada-Kolhapuri chappal controversy (2025) also highlighted this gap — international fashion houses can use traditional Indian designs without consequences unless India registers GIs internationally. WIPO's Lisbon Agreement provides a multilateral system for GI registration, which India is not yet a party to.
Trap 1 — "PCT (Patent Cooperation Treaty) is administered by WTO" → WRONG! PCT is administered by WIPO (World Intellectual Property Organization). WTO administers the TRIPS Agreement. WIPO and WTO are entirely separate international organisations with different memberships, mandates, and headquarters. This was directly tested in UPSC 2019. Never confuse WIPO (UN agency, Geneva, IPR treaties) with WTO (trade organisation, Geneva, TRIPS and trade rules).
Trap 2 — "Trademark protection lasts 10 years and expires" → WRONG! Trademark registration lasts 10 years but is renewable indefinitely. A trademark can last forever as long as renewal fees are paid and it remains in active use. This is fundamentally different from patents (fixed 20 years, non-renewable) and copyrights (fixed life+60 years). Trademarks are the ONLY major IP right with potentially unlimited duration.
Trap 3 — "Copyright requires registration to be valid" → WRONG! Copyright protection is automatic from the moment of creation — no registration, no formalities, no fees required. This is established by the Berne Convention (1886) principle of "automatic protection." Registration is optional in India (Copyright Act 1957 allows it) and provides legal evidentiary benefits but is NOT a prerequisite for copyright protection. This is a classic UPSC misdirection.
Trap 4 — "Section 3(d) violates India's TRIPS obligations" → WRONG! Section 3(d) does NOT violate TRIPS. TRIPS Article 27.1 requires patents for inventions that are new, involve an inventive step and are capable of industrial application. Trivial modifications (new salt forms, new dosages without efficacy improvement) do NOT meet the "inventive step" requirement. India's Supreme Court (Novartis v. India 2013) held that Section 3(d) is fully compliant with TRIPS — it simply clarifies what counts as a genuine inventive step in pharmaceuticals. The Court rejected the argument that TRIPS required granting such patents.
Trap 5 — "India's GI tags are protected globally like patents" → WRONG! GI protection is territorial — a GI tag registered in India protects the product only within India. For global protection, India must separately register the GI in each target country or region. This is why the Basmati case in the USA was problematic — India's domestic GI had no force in the US patent office. The Prada-Kolhapuri chappal controversy (2025) also highlighted this gap — international fashion houses can use traditional Indian designs without consequences unless India registers GIs internationally. WIPO's Lisbon Agreement provides a multilateral system for GI registration, which India is not yet a party to.
